Trigger point injection in myofscial pain syndrom
PDF
Cite
Share
Request
Researches
VOLUME: 7 ISSUE: 3
P: 89 - 93
September 2011

Trigger point injection in myofscial pain syndrom

Med J Bakirkoy 2011;7(3):89-93
1. Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, I. Anesteziyoloji ve Reanimasyon Kliniği, İstanbul
No information available.
No information available
Received Date: 03.01.2011
Accepted Date: 23.02.2011
PDF
Cite
Share
Request

ABSTRACT

Conclusion:

The local anesthetic and steroid injection at the trigger point seems to be beneficial in myofascial pain syndrome. In conclusion, this therapy may be a alternative to other methods in the management of myofascial pain syndrome.

Results:

Pain control values with treatment were statistically better compared with pretreatment values. VAS scores, PMSS and number of trigger points significantly reduced 1 and 2 months after lidocaine and triamsinolone injection at the trigger point (p<0.01).

Material and Methods:

One hundred and sixty-four patients with myofascial pain syndrome were recruited into the study. Patients received lidocaine 2% (5ml)+NaCl 0.9% (5ml) onto the trigger points at first day. Lidocaine 2% (5ml)+triamsinolone 40mg (1ml)+NaCl 0.9% (4ml) were injected to the patients at fourth and eighth day. Pain was evaluated with visual analogue score (VAS), palpable muscle spasm scoring (PMSS) and number of trigger point at baseline, first and second month.

Objective:

Myofascial pain syndrome is a disorder characterized by hypersensitive sites called trigger points at one or more muscles and/or connective tissue, leading to pain, muscle spasm, sensitivity, rigor, weakness. The aim of this study was to explore the efficacy of lidocain and steroid in myofascial pain syndrome.

Keywords:
Myofascial pain syndrome, trigger point injection, lidocaine, triamsinolone